TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/24 16:04 | 11/11/24 | EBS | Emergent Biosolutions Inc. | DE | Health | Drug | Pharmaceutical Preparations | White Marvin L | MD | D | S | -171 | 11.97 | 0 | -14 | -21 | 54 | D | |||||||||||||||
3/5/24 16:06 | 3/2/24 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | White Marvin L | WA | DO | P,CEO | M.dm | 0 | 0.00 | 0 | 23 | 50 | 67 | D | ||||||||||||||
1/30/24 18:02 | 1/28/24 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | White Marvin L | WA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 5 | 12 | 45 | D | ||||||||||||||
3/7/23 16:37 | 3/3/23 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | White Marvin L | WA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 10 | 31 | 40 | D | ||||||||||||||
1/30/23 13:07 | 1/29/23 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | White Marvin L | WA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 5 | 19 | 31 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |